Kops Lab's Avatar

Kops Lab

@kopslab.bsky.social

Interested in all things chromosome segregation and aneuploidy | Director & PI at Hubrecht Institute

131 Followers  |  85 Following  |  17 Posts  |  Joined: 14.02.2025  |  1.7746

Latest posts by kopslab.bsky.social on Bluesky

New preprint from our lab! Led by Emine Ali and @maxraas.bsky.social

See the highlights below!

01.12.2025 14:53 β€” πŸ‘ 6    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0

Our story on the kinetochore composition of the ciliate Tetrahymena thermophila is out now on bioRxiv! We find surprisingly many orthologs of conventional kinetochore components, but also components that have very different evolutionary origins. A 🧡 (1/11)

Check it out here: tinyurl.com/4ectm9x4

01.12.2025 14:05 β€” πŸ‘ 24    πŸ” 10    πŸ’¬ 2    πŸ“Œ 2

Surprise β€” it wasn’t: RNA-seq and histology show that moderate/high CIN causes massive cell death, triggering regeneration without immune infiltration β€” providing the non–cell-autonomous push that fuels tumorigenesis. (5/5)

04.11.2025 11:41 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 1    πŸ“Œ 0

One possibility of such a mechanism: CIN may mimic TPA in promoting tumorigenesis. Indeed, moderate/high CIN could partially replace TPA in the DMBA/TPA regimen.
But what TPA effect was CIN mimicking? Inflammation? (4/5)

04.11.2025 11:41 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 1    πŸ“Œ 0

Now the twist: despite being induced under moderate/high CIN, these tumors are made of low CIN cells across other tumor types.

So what’s happening?

Moderate/high CIN drives the outgrowth of rare low-CIN tumor cells through a non–cell-autonomous mechanism which doesn't happen in only low CIN. (3/5)

04.11.2025 11:41 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 1    πŸ“Œ 0

CIN levels matter!

We used CiMKi mice to induce and monitor skin tumors across five CIN levels in combination with DMBA/TPA treatment.

Low β†’ more tumors but no effect on onset or growth
Moderate β†’ more tumors earlier onset and larger growth
High β†’ fewer tumors but earlier and earlier growth (2/5)

04.11.2025 11:41 β€” πŸ‘ 1    πŸ” 1    πŸ’¬ 1    πŸ“Œ 0
Preview
Non-cell-autonomous mechanisms of tumor initiation and relapse by chromosomal instability Chromosomal instability (CIN) is a hallmark of cancer, and a primary cause of genetic heterogeneity in tumors. Depending on the degree of CIN and the affected tissue, CIN can promote or suppress tumor...

Ever wondered how chromosomal instability (CIN) influences tumorigenesis? And how does it contribute to shaping the tumor microenvironment?
In our latest preprint, we used the CiMKi model to induce and monitor skin tumors across five levels of CIN

tinyurl.com/52tuk88z

Here's what we find (1/5):

04.11.2025 11:41 β€” πŸ‘ 9    πŸ” 2    πŸ’¬ 1    πŸ“Œ 0
Post image Post image Post image

Ready to establish your own research group at the Hubrecht Institute for Molecular and Developmental Biology? We’re seeking a tenure-track group leader to develop an innovative research line within our vibrant scientific community. Learn more & apply! https://f.mtr.cool/jncxfqkuds

26.09.2025 13:53 β€” πŸ‘ 15    πŸ” 14    πŸ’¬ 0    πŸ“Œ 2

Altogether, our findings highlight the need to explore the tissue context of p53 responses to aneuploidy. We propose that future efforts should integrate the use of appropriate models of diverse healthy and pre-cancer human tissues.
(8/8)

09.07.2025 10:32 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

Finally, we show that losses, but not gains, are more universally linked with p53 deficiency across cancer types. This association has been previously made and highlights an exciting direction to explore the role of p53 responses to aneuploidy.
(7/8)

09.07.2025 10:32 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 1    πŸ“Œ 0

Surprisingly, we find that neither arm-level or whole-chromosome CNAs correlate with p53 deficiency. This is particularly interesting given the role of p53 in responding to DNA damage, which is often linked to arm-level copy number alterations.
(6/8)

09.07.2025 10:32 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 1    πŸ“Œ 0

This lead us to ask the following question: can specific features of aneuploidy better distinguish p53 proficient and deficient tumors? To explore this we focused on the type (arm- or whole-chromosome) and direction of copy-number alteration (CNA).
(5/8)

09.07.2025 10:32 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 1    πŸ“Œ 0

We were excited to find that p53 inactivation is neither sufficient nor necessary for tumors to accumulate a high degree of aneuploidy. We find that tumors with high aneuploidy yet intact p53 are common, and also that p53 inactivation does not invariably lead to highly aneuploid tumors.
(4/8)

09.07.2025 10:32 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 1    πŸ“Œ 0

To fully capture the p53 status we defined p53 deficiency as either TP53 mutations or alterations that phenocopy TP53 loss. Aneuploidy was defined as arm- or whole-chromosome copy number alterations (CNAs).
(3/8)

09.07.2025 10:32 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 1    πŸ“Œ 0

Despite decades of research, it is still unclear whether p53 protects against particular forms of copy number alterations and whether it does so universally across cancer types. To investigate this we systematically analyzed TCGA tumors across 31 cancer types.
(2/8)

09.07.2025 10:32 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 1    πŸ“Œ 0
Cancer type-specific association of p53 deficiency with aneuploidy and chromosome losses Aneuploidy and mutations in the TP53 tumor suppressor gene are among the most frequent genetic alterations in cancer, and p53 inactivation is considered an important contributor to the emergence of cancer aneuploidy. It is unclear, however, if p53 protects against particular forms of copy number alterations and whether it does so universally across cancer types. By analyzing p53 status and various aneuploidy features in 31 cancer types in the TCGA database, we verify that on a pan-cancer level p53-deficient cancers tend to have a higher degree of aneuploidy. However, for many cancer types, the average degree of aneuploidy is similar in p53-proficient and -deficient samples, and a substantial degree of aneuploidy can accumulate with intact p53 in almost all cancer types. Neither arm-level nor whole chromosome aneuploidy but rather chromosome loss events distinguish p53-deficient from proficient cancers. p53 inactivation is therefore neither sufficient nor necessary for the emergence of cancer aneuploidy, but is associated with the degree of aneuploidy in a subset of cancer types and more universally with chromosome losses. Our findings underscore the poorly understood nature of aneuploidy emergence in cancer and shed new light on the role of p53 therein. ### Competing Interest Statement The authors have declared no competing interest. Dutch Cancer Society (KWF Kankerbestrijding) European Research Council, ERC-SyG 855158

Our new preprint is out! We revisit the associations between p53 status and cancer aneuploidy using TCGA data. Here’s a breakdown of our findings. Important work spearheaded by the talented PhD candidate Joana Marques. Check it out here: www.biorxiv.org/content/10.1...
(1/8)🧡

09.07.2025 10:32 β€” πŸ‘ 11    πŸ” 1    πŸ’¬ 1    πŸ“Œ 0
Post image

A few weeks ago, we said goodbye to long-term Kops lab member Emine Ali, our resident protistologist.
We wish Emine all the best in her future career.

08.07.2025 13:35 β€” πŸ‘ 4    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image

Spending a few days in beautiful Heidelberg for the 5th EMBL partnership conference. Our Hubrecht institute is EMBL partner and it has been wonderful to see the exciting science of the other partner institutes! @embl.org @hubrechtinstitute.bsky.social

02.04.2025 06:58 β€” πŸ‘ 9    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0

An amazing inaugural Hubrecht Symposium on Developmental Biology, bringing the Dutch community together and getting inspired by amazing science! A big thank you to the speakers, the organizing committee and the many dedicated Hubrechters who made it happen.

25.03.2025 13:29 β€” πŸ‘ 2    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Video thumbnail

πŸš€Ever wondered if there's a universal rule of spindle scaling across eukaryotes? Turns out, there is! Our study reveals an evolutionarily conserved principle driven by a surprising factor: chromosome crowding. πŸ§΅πŸ‘‡
shorturl.at/MmPNr

10.03.2025 16:24 β€” πŸ‘ 18    πŸ” 5    πŸ’¬ 1    πŸ“Œ 1
Expression of the timing protein LIN-39 (green) in C. elegans

Expression of the timing protein LIN-39 (green) in C. elegans

How do cells measure time? Despite its fundamental role in development, the underlying mechanisms remain unclear. An NWO ENW-XL grant allows a research consortium from the Hubrecht Institute, AMOLF, TU Delft, and ENS Paris to study timing regulation in C. elegans. www.hubrecht.eu/how-do-cells...

14.02.2025 09:11 β€” πŸ‘ 7    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0

Phylogenetic profile of CENP-E across holocentric and monocentric taxa. (A–D) CENP-E conservation in (A) the phylum Nematoda, (B) the phylum Vertebrata, (C) the insect order Hemiptera and (D) the insect order Diptera. Lineages with an inferred CENP-E loss are highlighted with a coloured box. Holocentric lineages are indicated with β€˜H’ and monocentric lineages with β€˜M’, as well as with a graphic depiction of holocentric and monocentric chromosomes.

Phylogenetic profile of CENP-E across holocentric and monocentric taxa. (A–D) CENP-E conservation in (A) the phylum Nematoda, (B) the phylum Vertebrata, (C) the insect order Hemiptera and (D) the insect order Diptera. Lineages with an inferred CENP-E loss are highlighted with a coloured box. Holocentric lineages are indicated with β€˜H’ and monocentric lineages with β€˜M’, as well as with a graphic depiction of holocentric and monocentric chromosomes.

Ana Almeida, Helder Rocha, Maximilian Raas, Geert Kops, Reto Gassmann, Helder Maiato @i3suporto.bsky.social, et al. dissect the relationship between kinetochore size & CENP-E dependence for chromosome alignment.

journals.biologists.com/jcs/article/...

journals.biologists.com/jcs/article/...

09.01.2025 12:03 β€” πŸ‘ 6    πŸ” 4    πŸ’¬ 1    πŸ“Œ 0

@kopslab is following 20 prominent accounts